JNJ

237.78

+1.48%↑

UNH

268.4

-2.59%↓

TMO

542.28

-3.73%↓

ABT

109.09

+0.87%↑

ISRG

476.03

-0.43%↓

JNJ

237.78

+1.48%↑

UNH

268.4

-2.59%↓

TMO

542.28

-3.73%↓

ABT

109.09

+0.87%↑

ISRG

476.03

-0.43%↓

JNJ

237.78

+1.48%↑

UNH

268.4

-2.59%↓

TMO

542.28

-3.73%↓

ABT

109.09

+0.87%↑

ISRG

476.03

-0.43%↓

JNJ

237.78

+1.48%↑

UNH

268.4

-2.59%↓

TMO

542.28

-3.73%↓

ABT

109.09

+0.87%↑

ISRG

476.03

-0.43%↓

JNJ

237.78

+1.48%↑

UNH

268.4

-2.59%↓

TMO

542.28

-3.73%↓

ABT

109.09

+0.87%↑

ISRG

476.03

-0.43%↓

Search

Quanterix Corp

Închisă

SectorSănătate

5.85 -7

Rezumat

Modificarea prețului

24h

Curent

Minim

5.83

Maxim

6.36

Indicatori cheie

By Trading Economics

Venit

-3.5M

-34M

Vânzări

16M

40M

Marjă de profit

-83.479

Angajați

471

EBITDA

5.7M

-31M

Recomandări

By TipRanks

Recomandări

Neutru

Prognoză pe 12 luni

+18.67% upside

Dividende

By Dow Jones

Următoarele câștiguri

16 mar. 2026

Statistici piață

By TradingEconomics

Capitalizare de piață

66M

304M

Deschiderea anterioară

12.85

Închiderea anterioară

5.85

Sentimentul știrilor

By Acuity

50%

50%

147 / 352 Clasament în Healthcare

Scor tehnic

By Trading Central

Încredere

Neutral Evidence

Quanterix Corp Grafic

Performanțele din trecut nu reprezintă un indicator fiabil al rezultatelor viitoare.

Știri relevante

5 feb. 2026, 23:57 UTC

Câștiguri

Naver Has Record Year Despite Weaker Final Quarter

5 feb. 2026, 23:45 UTC

Acțiuni populare

Stocks to Watch: Amazon, Coty, Gen Digital, Roblox

5 feb. 2026, 22:26 UTC

Câștiguri

REA Group Lifts Dividend, Announces Buyback as 1st Half Profit Rises 9% -- Update

5 feb. 2026, 22:00 UTC

Câștiguri

REA Group Lifts Dividend, Announces Buyback as 1st Half Profit Rises 9%

5 feb. 2026, 23:47 UTC

Market Talk

Global Equities Roundup: Market Talk

5 feb. 2026, 23:47 UTC

Market Talk

Nikkei May Fall After U.S. Tech Stock Drops -- Market Talk

5 feb. 2026, 23:43 UTC

Market Talk

Gold Falls on Spillover Impact From Cryptocurrencies' Selloff -- Market Talk

5 feb. 2026, 23:37 UTC

Market Talk

Glencore Shares Look Cheap After Failed Takeover Talks -- Market Talk

5 feb. 2026, 23:20 UTC

Câștiguri
Achiziții, Fuziuni, Preluări

Amazon to Spend $200 Billion as It Accelerates AI Projects -- 5th Update

5 feb. 2026, 23:11 UTC

Market Talk

Amazon CEO Confident in Return on $200B Investment -- Market Talk

5 feb. 2026, 23:09 UTC

Câștiguri

Naver 2025 Net KRW1.820T Vs. Net KRW1.932T >035420.SE

5 feb. 2026, 23:08 UTC

Câștiguri

Naver 2025 Oper Pft KRW2.208T Vs. Pft KRW1.979T >035420.SE

5 feb. 2026, 23:07 UTC

Câștiguri

Naver 2025 Rev KRW12.035T Vs. KRW10.738T >035420.SE

5 feb. 2026, 23:03 UTC

Market Talk
Câștiguri

REA's Update Looks Negative Despite A$200M Buyback -- Market Talk

5 feb. 2026, 23:03 UTC

Câștiguri
Achiziții, Fuziuni, Preluări

Bitcoin Booster's $12 Billion Loss Headlines Crypto's Worst Day Since 2022 Crash -- WSJ

5 feb. 2026, 23:00 UTC

Câștiguri

Naver 4Q Net Profit Missed FactSet-Compiled Consensus

5 feb. 2026, 23:00 UTC

Câștiguri

Naver 4Q Net KRW164.60B Vs. Net KRW514.00B >035420.SE

5 feb. 2026, 22:59 UTC

Câștiguri

Naver 4Q Oper Pft KRW610.60B Vs. Pft KRW542.00B >035420.SE

5 feb. 2026, 22:59 UTC

Câștiguri

Naver 4Q Rev KRW3.195T Vs. KRW2.886T >035420.SE

5 feb. 2026, 22:52 UTC

Câștiguri

Alphabet Stock Is Taking a Hit After Strong Earnings. Don't Panic. -- Barrons.com

5 feb. 2026, 22:45 UTC

Câștiguri

Amazon Stock Falls Sharply on Earnings. Spending Continues to Soar. -- Barrons.com

5 feb. 2026, 22:37 UTC

Market Talk

Woolworths's Profit Margin Likely Faces 2Q Squeeze -- Market Talk

5 feb. 2026, 22:11 UTC

Câștiguri

REA Group Lifts Dividend, Announces Buyback as 1H Profit Rises 9% -- Update

5 feb. 2026, 22:03 UTC

Câștiguri
Achiziții, Fuziuni, Preluări

Amazon to Spend $200 Billion as It Accelerates AI Projects -- 4th Update

5 feb. 2026, 22:01 UTC

Câștiguri

Reddit Stock Jumps on Earnings. CFO Cites Modest AI Spending. -- Barrons.com

5 feb. 2026, 21:59 UTC

Market Talk
Achiziții, Fuziuni, Preluări

What's Next For Rio Tinto, Glencore After Deal Talks Fail? -- Market Talk

5 feb. 2026, 21:51 UTC

Câștiguri
Achiziții, Fuziuni, Preluări

Saylor's Strategy Posts $12 Billion Quarterly Loss on Bitcoin Selloff -- WSJ

5 feb. 2026, 21:50 UTC

Market Talk
Achiziții, Fuziuni, Preluări

Basic Materials Roundup: Market Talk

5 feb. 2026, 21:49 UTC

Câștiguri

Why Google's Bad News Was Good News for Broadcom and Nvidia -- Barrons.com

5 feb. 2026, 21:45 UTC

Câștiguri

REA Group Lifts Dividend, Announces Buyback as 1H Profit Rises 9%

Comparație

Modificare preț

Quanterix Corp Așteptări

Obiectiv de preț

By TipRanks

18.67% sus

Prognoză pe 12 luni

Medie 7.5 USD  18.67%

Maxim 8 USD

Minim 7 USD

În baza a 2 analiști de pe Wall Street care oferă obiective de preț pe 12 luni pentruQuanterix Corp - Dist în ultimele 3 luni.

Consens privind evaluarea

By TipRanks

Neutru

2 ratings

0

Cumpărare

2

Păstrare

0

Vânzare

Scor tehnic

By Trading Central

5.34 / 6.015Suport & Rezistență

Termen scurt

Neutral Evidence

Termen mediu

Bullish Evidence

Termen lung

No Evidence

Sentiment

By Acuity

147 / 352 Clasament în Sănătate

Sentimentul știrilor

Neutral

Volatilitate

Sub medie

Volumul știrilor (RCV)

Peste medie

Date financiare

Cheltuieli de vânzare și administrare

Cheltuieli de exploatare

Profit pre-impozitare

Vânzări

Costul vânzărilor

Profit brut din vânzări

Cheltuieli cu dobânzile pe datorie

EBITDA

Profit operațional

$

Despre Quanterix Corp

Quanterix Corporation, a life sciences company, engages in development and marketing of digital immunoassay platforms that advances precision health for life sciences research and diagnostics in North America, Europe, the Middle East, Africa, and the Asia Pacific regions. The company offers HD-X instrument, a protein detection platform; and SR-X instrument that enables researchers to apply Simoa detection in an expanded range of applications. It also provides SP-X instrument that is based on Simoa planar array technology for the measurement of multiplex chemiluminescent immunoassays. The company's products include assays include all components required to run enzyme-based immunoassay, such as beads, capture and detector reagents, and enzyme reagents and substrate; and replacement parts, reagents, and antibodies. In addition, it offers contract research services, including sample testing, homebrew assay development, custom assay development, lucent diagnostic, and LDT testing services. The company primarily operates in the areas of neurology, oncology, cardiology, infectious diseases, and inflammation. It sells its products for the life science research sector primarily to laboratories associated with academic and governmental research institutions, as well as pharmaceutical, biotechnology, and contract research companies through a direct field sale, support organizations, and distributors or sales agents. The company was formerly known as Digital Genomics, Inc. and changed its name to Quanterix Corporation in August 2007. Quanterix Corporation was incorporated in 2007 and is headquartered in Billerica, Massachusetts.
help-icon Live chat